Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05892328 · ClinicalTrials.gov registry record · NA

Watermelon Dose Response Blood Pressure Study

A NA study of Cardiovascular Diseases and Pre Hypertension, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.

Active
Registry status
NA
Development phase
36
Enrollment target
1
Study location

NCT05892328 is a NA study of Cardiovascular Diseases and Pre Hypertension that is active but no longer recruiting, run by Clinical Nutrition Research Center, Illinois Institute of Technology. The registered enrollment target is 36 participants, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05892328, a NA study of Cardiovascular Diseases and Pre Hypertension, is active but no longer recruiting, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
36 participants
Enrollment target
1
Study location

Study Summary

1. Primary outcome: To evaluate the dose response effects of watermelon flesh in regulating Blood Pressure (BP) in individuals with pre-hypertension. 2. Secondary outcomes: To study the dose-response effects of watermelon flesh intake on cardio-metabolic risk factors including plasma metabolic markers, lipid profile and nitrate/nitrite levels in individuals with pre-hypertension.

Interventions

  • OTHER Control
  • OTHER Watermelon Flesh Dose 1
  • OTHER Watermelon Flesh Dose 2

Study Locations (1)

Illinois

  • Clinical Nutrition Research Center - Chicago

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2023-04-07
Est. Completion 2026-03-01
Phase NA

What the Registry Record Tells You About NCT05892328

The ClinicalTrials.gov registry entry for NCT05892328 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The listed sponsor is Clinical Nutrition Research Center, Illinois Institute of Technology, which has 59 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 3 interventions - of which Control is the first listed.

NCT05892328 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT05892328 about?

NCT05892328 is a clinical study titled "Watermelon Dose Response Blood Pressure Study". 1. Primary outcome: To evaluate the dose response effects of watermelon flesh in regulating Blood Pressure (BP) in individuals with pre-hypertension. 2. Secondary outcomes: To study the dose-response effects of watermelon flesh intake on cardio-metabolic risk factors including plasma metabolic marke...

What is the current status of trial NCT05892328?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 36 participants. The study started on 2023-04-07. Estimated completion is 2026-03-01.

What conditions does trial NCT05892328 study?

This clinical trial studies the following conditions: Cardiovascular Diseases, Pre Hypertension.

What interventions are being tested in trial NCT05892328?

The interventions under investigation include: Control (OTHER), Watermelon Flesh Dose 1 (OTHER), Watermelon Flesh Dose 2 (OTHER).

Who is sponsoring clinical trial NCT05892328?

This trial is sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology, which has 59 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05892328 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiovascular Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.